DOPS adjuvant confers enhanced protection against malaria for VLP-TRAP based vaccines
Vaccination remains the most effective and essential prophylactic tool against infectious diseases. Enormous efforts have been made to develop effective vaccines against malaria but successes remain so far limited. Novel adjuvants may offer a significant advantage in the development of malaria vacci...
Main Authors: | Cabral-Miranda, G, Salman, AM, Mohsen, MO, Storni, FL, Roesti, ES, Skinner, MA, Heath, MD, Kramer, MF, Khan, SM, Janse, CJ, Hill, AVS, Bachmann, MF |
---|---|
Format: | Journal article |
Language: | English |
Published: |
MDPI
2018
|
Similar Items
-
DOPS Adjuvant Confers Enhanced Protection against Malaria for VLP-TRAP Based Vaccines
by: Gustavo Cabral-Miranda, et al.
Published: (2018-11-01) -
Virus-like particle (VLP) plus microcrystalline tyrosine (MCT) adjuvants enhance vaccine efficacy improving T and B cell immunogenicity and protection against Plasmodium berghei/vivax
by: Cabral-Miranda, G, et al.
Published: (2017) -
Vaccination with nanoparticles combined with micro-adjuvants protects against cancer
by: Mohsen, MO, et al.
Published: (2019) -
Virus-Like Particle (VLP) Plus Microcrystalline Tyrosine (MCT) Adjuvants Enhance Vaccine Efficacy Improving T and B Cell Immunogenicity and Protection against Plasmodium berghei/vivax
by: Gustavo Cabral-Miranda, et al.
Published: (2017-05-01) -
Structural Insight into CVB3-VLP Non-Adjuvanted Vaccine
by: Minna M. Hankaniemi, et al.
Published: (2020-08-01)